Clinical trial
Levosimendan Versus Dobutamine in Shock Patients
NCT00093301 · Wentworth Area Health Services, Other · Unknown status
Key facts
| NCT number | NCT00093301 |
|---|---|
| Title | Levosimendan Versus Dobutamine in Shock Patients |
| Official title | Efficacy of Levosimendan in the Critically Ill Patients With Unstable Hemodynamics (the LICI Study) - A Double Blind Randomized Pilot Study |
| Lead sponsor | Wentworth Area Health Services, Other |
| Collaborators | Abbott Industry |
| Status | Unknown status |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Cardiogenic Shock, Septic Shock |
| Intervention type | Drug |
| Interventions | Levosimendan, Dobutamine |
| Enrollment | 40 |
| Start date | Oct 1, 2004 |
| Completion | Apr 1, 2006 |
| First posted | Oct 7, 2004 |
| Last update posted | Jun 24, 2005 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: